Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


Recent & Breaking News (TSX:EDT)

Spectral Announces Third Quarter Results and Provides Corporate Update

GlobeNewswire November 12, 2021

Spectral to Present at the Benzinga Global Small Cap Conference on October 27, 2021

GlobeNewswire October 25, 2021

Spectral and Dialco Announce Dr. John Kellum to Be Featured as Keynote Lecturer at the 39th Vicenza Course on AKI and CRRT

GlobeNewswire October 20, 2021

Spectral Medical's CMO Recognized as a World Expert in Sepsis; Supports World Sepsis Day and Sepsis Awareness Month

GlobeNewswire September 13, 2021

Spectral Medical Announces its Participation at Upcoming Investor Conferences

GlobeNewswire August 23, 2021

Spectral Announces Second Quarter Results and Provides Corporate Update

GlobeNewswire August 13, 2021

Spectral Medical Announces Internal Reorganization of its Wholly Owned Subsidiary Dialco Medical to Enhance Operations and Accelerate Commercialization

GlobeNewswire August 9, 2021

Spectral Medical Inc. (TSX:EDT) provides Tigris clinical trial update

Brieanna McCutcheon  July 28, 2021

Spectral Medical Inc. Provides Tigris Clinical Trial Update

GlobeNewswire July 28, 2021

Spectral Medical Closes $10M Bought-Deal Offering

John Ballem  July 27, 2021

Spectral Medical Inc. Closes $10 Million Offering of Units

GlobeNewswire July 27, 2021

Spectral Medical (TSX:EDT) announces $10 million offering

Trevor Abes  July 21, 2021

Spectral Medical Inc. Announces $10 Million Offering

GlobeNewswire July 21, 2021

Spectral Medical Inc. Announces Overnight Marketed Offering

GlobeNewswire July 20, 2021

Dialco Medical Inc. Engages CROMSOURCE as Contract Research Organization Partner for DIMI IDE Trial

GlobeNewswire June 7, 2021

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire June 4, 2021

Spectral Announces First Quarter Results and Provides Corporate Update

GlobeNewswire May 14, 2021

Spectral Medical to Present at the Q2 Virtual Investor Summit on May 17th

Newsfile May 11, 2021

Spectral Medical's Wholly-Owned Subsidiary Dialco Medical Announces DIMI Usability Trial Posted on the ClinicalTrials.gov Website

GlobeNewswire May 5, 2021

Spectral Medical’s (TSX:EDT) Dialco secures 20-year licensing agreement for hemodialysis device

Trevor Abes  April 8, 2021